Journal Logo

October 1999 - Volume 9 - Issue 5
pp: 421-530

PDF Only



PDF Only


Isolated limb perfusion with tumour necrosis factor-α and melphalan with or without interferon-γ; for the treatment of in-transit melanoma metastases: a multicentre randomized Phase II study

Liénard, D.; Eggermont, A. M. M.; Koops, H. Schraffordt; More

Melanoma Research. 9(5):491-502, October 1999.

Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferon α2a and tamoxifen in metastatic melanoma

Sertoli, M. R.; Queirolo, P.; Bajetta, E.; More

Melanoma Research. 9(5):503-510, October 1999.


PDF Only



PDF Only